The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates.
Stovner LJ, Hagen K, Linde M, Steiner TJ. · 2022
Read The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. by Stovner LJ, Hagen K, Linde M, Steiner TJ. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9004186.txt.
Introduction
Stovner, Hagen, Linde, and Steiner update the world picture of headache and test why estimates vary so much. Headache disorders rank among the most common and disabling conditions. The team gathered every population study they could find up to 2020. Clinic-based samples were shut out. In all, 357 publications fed the work. Most came from rich countries. Prevalence figures were pulled for each headache type. Methods were coded with equal care.
Active headache disorder touched 52.0% of people in the pooled estimate. Migraine alone reached 14.0% in the same pooled work. Tension-type headache and near-daily headache followed behind. Each day, a large share of the world has a headache. The numbers matched global burden figures for migraine. Method choices explained part of the spread between studies. How questions were asked mattered. So did sample size and who was sampled.
Catalog record
| CREATOR | Stovner LJ, Hagen K, Linde M, Steiner TJ. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates By Lars Jacob Stovner, Knut Hagen, Mattias Linde, Timothy J. Steiner Published in: The Journal of Headache and Pain DOI: 10.1186/s10194-022-01402-2 ABSTRACT Background According to the Global Burden of Disease (GBD) study, headache disorders are among the most prevalent and disabling conditions worldwide. GBD builds on epidemiological studies (published and unpublished) which are notable for wide variations in both their methodologies and their prevalence estimates. Our first aim was to update the documentation of headache epidemiological studies, summarizing global prevalence estimates for all headache, migraine, tension-type headache (TTH) and headache on ≥15 days/month (H15+), comparing these with GBD estimates and exploring time trends and geographical variations. Our second aim was to analyse how methodological factors influenced prevalence estimates. Methods In a narrative review, all prevalence studies published until 2020, excluding those of clinic populations, were identified through a literature search. Prevalence data were extracted, along with those related to methodology, world region and publication year. Bivariate analyses (correlations or comparisons of means) and multiple linear regression (MLR) analyses were performed. Results From 357 publications, the vast majority from high-income countries, the estimated global prevalence of active headache disorder was 52.0% (95%CI 48.9–55.4), of migraine 14.0% (12.9–15.2), of TTH 26.0% (22.7–29.5) and of H15+ 4.6% (3.9–5.5). These estimates were comparable with those of migraine and TTH in GBD2019, the most recent iteration, but higher for headache overall. Each day, 15.8% of the world’s population had headache. MLR analyses explained less than 30% of the variation. Methodological factors contributing to variation, were publication year, sample size, inclusion of probable diagnoses, sub-population sampling (e.g., of health-care personnel), sampling method (random or not), screening question (neutral, or qualified in severity or presumed cause) and scope of enquiry (headache disorders only or multiple other conditions). With these taken into account, migraine prevalence estimates increased over the years, while estimates for all headache types varied between world regions. Conclusion The review confirms GBD in finding that headache disorders remain highly prevalent worldwide, and it identifies methodological factors explaining some of the large variation between study findings. These variations render uncertain both the increase in migraine prevalence estimates over time, and the geographical differences. More and better studies are needed in low- and middle-income countries. Supplementary Information The online version contains supplementary material available at 10.1186/s10194-022-01402-2. INTRODUCTION Documenting the burden of headache disorders has become an important task, brought to attention by the Global Campaign against Headache [1]. Through the Global Burden of Disease (GBD) study, headache disorders are revealed as one of the major public-health concerns globally and in all countries and world regions [2]. In the 2019 iteration (GBD2019), migraine alone was second among the causes of disability, and first among women under 50 years of age [3]. GBD estimates are now updated annually to monitor changes in disease burden around the globe, and thereby forecast future needs in health services. For the various disorders it considers, GBD uses multiple data sources (epidemiological studies, health registers, official statistics, hospital data etc) to make best-informed estimates of prevalence and burden. For headache disorders, however, epidemiological studies are the only source, but these are now available from many countries, including several yet unpublished from the Global Campaign. While GBD handles data for all diseases in a relatively uniform way, the quality of its estimates for each disease depends on a good understanding of the particular methodological issues that may influence them. Headache epidemiology is a relatively young and immature discipline [4]. Studies follow general epidemiological principles, but the field has its peculiar methodological problems [4]. It is believed that the large variations in reported prevalences from country to country, and sometimes within countries, are to a large extent caused by methodological differences between studies, but this has not been explored empirically. Guidelines on performing and reporting headache epidemiological studies were published in 2014 [4]. They included criteria for judging the quality of studies from their reported methodology, and some adjustments to prevalence estimates were based upon these in the most detailed analysis of headache data, from GBD 2016 [2]. Nevertheless, these criteria were mostly theoretical, derived from general principles and expert opinion (see [2] Appendix). A better understanding of which methodological factors influence findings, and how, may be gained by reviewing metadata from all studies regarding how they collected and processed prevalence data, and analyzing findings across these studies accordingly. In 2007 we reviewed all published studies of the prevalence and burden of headache [5]. This review, highly cited, constituted the basis for collaboration between GBD and the Global Campaign against Headache [1] from GBD2010 onwards. Since the review, many new studies have provided more insight into the importance and influences of methodological issues, and this additional insight informed the methodological guidelines [4]. Here we update that review, and the documentation of headache epidemiological studies, summarizing global prevalence estimates for headache, migraine, tension-type headache (TTH) and headache on ≥15 days/month (H15+), comparing these with GBD estimates and exploring time trends and geographical variations. We also use the data and material from all the studies to analyse empirically how methodological factors might influence prevalence estimates. METHODS Literature search and data extraction A new literature search through PubMed, using the search terms “headache epidemiology”, “migraine epidemiology”, “headache prevalence” or “migraine prevalence”, identified studies published till the end of 2020. The search had been performed several times by LJS, KH and ML since our 2007 publication [5], and was concluded by LJS during the first month of 2021. This proved to be a time-consuming task. The search terms “headache” and “prevalence” returned more than 18,000 articles in PubMed, and “migraine” and “epidemiology” more than 6000, the great majority irrelevant for our purpose, but we found no way to restrict the search: additional terms such as “population-based” excluded many relevant papers. To include all parts of the world and all settings that were possible, we accepted data from all non-clinical samples as well as those that were strictly population-based, which entailed browsing all the pages in PubMed returned by these search terms. While most irrelevant papers could be dismissed from the title alone and some from the abstract, with only a few requiring perusal of their full texts. This introduced a subjective element in the search that was not in conformity with accepted methodology for systematic review. But by not restricting the literature search to strictly population-based samples we created a database similar to (although larger than) the one used in GBD studies of headache. This made our investigation of methodological factors more relevant to future evaluations of GBD estimates. Many additional studies were detected from the reference lists in relevant reviews (e.g. [6–8]). All articles were screened for population of interest, and excluded if reporting only samples derived from clinical sources (hospitals, medical practices, etc) or those described as patients or identified through patient groups. We extracted prevalence data for all headache, migraine, TTH and H15+, overall and for each gender. We also extracted data on the various aspects of methodology and design described below. When studies failed to provide value for a variable of interest, we stipulated a value, assigned a